Loading…

Signal characteristics of G protein-transactivated EGF receptor

The epidermal growth factor receptor (EGFR) tyrosine kinase recently was identified as providing a link to mitogen‐activated protein kinase (MAPK) in response to G protein‐coupled receptor (GPCR) agonists in Rat‐1 fibroblasts. This cross‐talk pathway is also established in other cell types such as H...

Full description

Saved in:
Bibliographic Details
Published in:The EMBO journal 1997-12, Vol.16 (23), p.7032-7044
Main Authors: Daub, Henrik, Wallasch, Christian, Lankenau, Andreas, Herrlich, Andreas, Ullrich, Axel
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The epidermal growth factor receptor (EGFR) tyrosine kinase recently was identified as providing a link to mitogen‐activated protein kinase (MAPK) in response to G protein‐coupled receptor (GPCR) agonists in Rat‐1 fibroblasts. This cross‐talk pathway is also established in other cell types such as HaCaT keratinocytes, primary mouse astrocytes and COS‐7 cells. Transient expression of either Gq‐ or Gi‐coupled receptors in COS‐7 cells allowed GPCR agonist‐induced EGFR transactivation, and lysophosphatidic acid (LPA)‐generated signals involved the docking protein Gab1. The increase in SHC tyrosine phosphorylation and MAPK stimulation through both Gq‐ and Gi‐coupled receptors was reduced strongly upon selective inhibition of EGFR function. Inhibition of phosphoinositide 3‐kinase did not affect GPCR‐induced stimulation of EGFR tyrosine phosphorylation, but inhibited MAPK stimulation, upon treatment with both GPCR agonists and low doses of EGF. Furthermore, the Src tyrosine kinase inhibitor PP1 strongly interfered with LPA‐ and EGF‐induced tyrosine phosphorylation and MAPK activation downstream of EGFR. Our results demonstrate an essential role for EGFR function in signaling through both Gq‐ and Gi‐coupled receptors and provide novel insights into signal transmission downstream of EGFR for efficient activation of the Ras/MAPK pathway.
ISSN:0261-4189
1460-2075
1460-2075
DOI:10.1093/emboj/16.23.7032